PubMed

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.

Marre M, Pinget M, Gin H, Thivolet C, Hanaire H, Robert JJ, Fontaine P.

Diabetes Metab. 2009 Nov 12. [Epub ahead of print]PMID: 19914118 [PubMed - as supplied by publisher]Related articles

Polymorphisms of the lamina maturation pathway and their association with the metabolic syndrome: the DESIR prospective study.

Fontaine-Bisson B, Alessi MC, Saut N, Fumeron F, Marre M, Dutour A, Badens C, Levy N, Tichet J, Juhan-Vague I, Trégouët DA, Balkau B, Morange PE.

J Mol Med. 2009 Oct 16. [Epub ahead of print]PMID: 19841875 [PubMed - as supplied by publisher]Related articles

Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proença C, Bacot F, Balkau B, Belisle A, Borch-Johnsen K, Charpentier G, Dina C, Durand E, Elliott P, Hadjadj S, Järvelin MR, Laitinen J, Lauritzen T, Marre M, Mazur A, Meyre D, Montpetit A, Pisinger C, Posner B, Poulsen P, Pouta A, Prentki M, Ribel-Madsen R, Ruokonen A, Sandbaek A, Serre D, Tichet J, Vaxillaire M, Wojtaszewski JF, Vaag A, Hansen T, Polychronakos C, Pedersen O, Froguel P, Sladek R.

Nat Genet. 2009 Oct;41(10):1110-5. Epub 2009 Sep 6. Erratum in: Nat Genet. 2009 Oct;41(10):1156. PMID: 19734900 [PubMed - indexed for MEDLINE]Related articles

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.

Zoungas S, de Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, MacMahon S, Marre M, Neal B, Patel A, Woodward M, Chalmers J; ADVANCE Collaborative Group, Cass A, Glasziou P, Harrap S, Lisheng L, Mancia G, Pillai A, Poulter N, Perkovic V, Travert F.

Diabetes Care. 2009 Nov;32(11):2068-74. Epub 2009 Aug 3.PMID: 19651921 [PubMed - in process]Related articles

Genetic variant in HK1 is associated with a proanemic state and A1C but not other glycemic control-related traits.

Bonnefond A, Vaxillaire M, Labrune Y, Lecoeur C, Chèvre JC, Bouatia-Naji N, Cauchi S, Balkau B, Marre M, Tichet J, Riveline JP, Hadjadj S, Gallois Y, Czernichow S, Hercberg S, Kaakinen M, Wiesner S, Charpentier G, Lévy-Marchal C, Elliott P, Jarvelin MR, Horber F, Dina C, Pedersen O, Sladek R, Meyre D, Froguel P.

Diabetes. 2009 Nov;58(11):2687-97. Epub 2009 Aug 3.PMID: 19651813 [PubMed - in process]Related articles

Functional annotations of diabetes nephropathy susceptibility loci through analysis of genome-wide renal gene expression in rat models of diabetes mellitus.

Hu Y, Kaisaki PJ, Argoud K, Wilder SP, Wallace KJ, Woon PY, Blancher C, Tarnow L, Groop PH, Hadjadj S, Marre M, Parving HH, Farrall M, Cox RD, Lathrop M, Vionnet N, Bihoreau MT, Gauguier D.

BMC Med Genomics. 2009 Jul 9;2:41.PMID: 19586551 [PubMed - in process]Related articlesFree article

Glucose control in critically ill patients.

Mohammedi K, Roussel R, Marre M.

N Engl J Med. 2009 Jul 2;361(1):90-1; author reply 91-2. No abstract available. PMID: 19579273 [PubMed - indexed for MEDLINE]Related articles

Kallikrein protects against microalbuminuria in experimental type I diabetes.

Bodin S, Chollet C, Goncalves-Mendes N, Gardes J, Pean F, Heudes D, Bruneval P, Marre M, Alhenc-Gelas F, Bouby N.

Kidney Int. 2009 Aug;76(4):395-403. Epub 2009 Jun 10.PMID: 19516248 [PubMed - in process]Related articles

Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE.

Fontaine P, Gin H, Pinget M, Thivolet C, Hanaire H, Robert JJ, Marre M, Venkatanarasimhachar S.

Adv Ther. 2009 May;26(5):535-51. Epub 2009 Jun 2.PMID: 19513632 [PubMed - in process]Related articles

Adding liraglutide to oral antidiabetic drug monotherapy: efficacy and weight benefits.

Nauck M, Marre M.

Postgrad Med. 2009 May;121(3):5-15.PMID: 19491535 [PubMed - indexed for MEDLINE]Related articlesFree article

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.

Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group.

J Am Soc Nephrol. 2009 Aug;20(8):1813-21. Epub 2009 May 14.PMID: 19443635 [PubMed - indexed for MEDLINE]Related articles

Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres.

Chabouis A, Berdugo M, Meas T, Erginay A, Laloi-Michelin M, Jouis V, Guillausseau PJ, M'bemba J, Chaine G, Slama G, Cohen R, Reach G, Marre M, Chanson P, Vicaut E, Massin P.

Diabetes Metab. 2009 Jun;35(3):228-32. Epub 2009 Apr 5.PMID: 19349202 [PubMed - indexed for MEDLINE]Related articles

G-allele of intronic rs10830963 in MTNR1B confers increased risk of impaired fasting glycemia and type 2 diabetes through an impaired glucose-stimulated insulin release: studies involving 19,605 Europeans.

Sparsø T, Bonnefond A, Andersson E, Bouatia-Naji N, Holmkvist J, Wegner L, Grarup N, Gjesing AP, Banasik K, Cavalcanti-Proença C, Marchand M, Vaxillaire M, Charpentier G, Jarvelin MR, Tichet J, Balkau B, Marre M, Lévy-Marchal C, Faerch K, Borch-Johnsen K, Jørgensen T, Madsbad S, Poulsen P, Vaag A, Dina C, Hansen T, Pedersen O, Froguel P.

Diabetes. 2009 Jun;58(6):1450-6. Epub 2009 Mar 26.PMID: 19324940 [PubMed - indexed for MEDLINE]Related articlesFree article

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).

Marre M, Shaw J, Brändle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S; LEAD-1 SU study group.

Diabet Med. 2009 Mar;26(3):268-78.PMID: 19317822 [PubMed - indexed for MEDLINE]Related articles

A rare variant in the visfatin gene (NAMPT/PBEF1) is associated with protection from obesity.

Blakemore AI, Meyre D, Delplanque J, Vatin V, Lecoeur C, Marre M, Tichet J, Balkau B, Froguel P, Walley AJ.

Obesity (Silver Spring). 2009 Aug;17(8):1549-53. Epub 2009 Mar 19.PMID: 19300429 [PubMed - indexed for MEDLINE]Related articles

Combined effects of MC4R and FTO common genetic variants on obesity in European general populations.

Cauchi S, Stutzmann F, Cavalcanti-Proença C, Durand E, Pouta A, Hartikainen AL, Marre M, Vol S, Tammelin T, Laitinen J, Gonzalez-Izquierdo A, Blakemore AI, Elliott P, Meyre D, Balkau B, Järvelin MR, Froguel P.

J Mol Med. 2009 May;87(5):537-46. Epub 2009 Mar 3.PMID: 19255736 [PubMed - indexed for MEDLINE]Related articles

Lowering blood pressure reduces renal events in type 2 diabetes.

de Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, Neal B, Poulter N, Harrap S, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Glasziou P, Grobbee DE, MacMahon S, Chalmers J; ADVANCE Collaborative Group.

J Am Soc Nephrol. 2009 Apr;20(4):883-92. Epub 2009 Feb 18.PMID: 19225038 [PubMed - indexed for MEDLINE]Related articles

Evaluating the association of common APOA2 variants with type 2 diabetes.

Duesing K, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

BMC Med Genet. 2009 Feb 13;10:13.PMID: 19216768 [PubMed - indexed for MEDLINE]Related articlesFree article

Common genetic variation near MC4R is associated with eating behaviour patterns in European populations.

Stutzmann F, Cauchi S, Durand E, Calvacanti-Proença C, Pigeyre M, Hartikainen AL, Sovio U, Tichet J, Marre M, Weill J, Balkau B, Potoczna N, Laitinen J, Elliott P, Järvelin MR, Horber F, Meyre D, Froguel P.

Int J Obes (Lond). 2009 Mar;33(3):373-8. Epub 2009 Jan 20.PMID: 19153581 [PubMed - in process]Related articles

Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations.

Meyre D, Delplanque J, Chèvre JC, Lecoeur C, Lobbens S, Gallina S, Durand E, Vatin V, Degraeve F, Proença C, Gaget S, Körner A, Kovacs P, Kiess W, Tichet J, Marre M, Hartikainen AL, Horber F, Potoczna N, Hercberg S, Levy-Marchal C, Pattou F, Heude B, Tauber M, McCarthy MI, Blakemore AI, Montpetit A, Polychronakos C, Weill J, Coin LJ, Asher J, Elliott P, Järvelin MR, Visvikis-Siest S, Balkau B, Sladek R, Balding D, Walley A, Dina C, Froguel P.

Nat Genet. 2009 Feb;41(2):157-9. Epub 2009 Jan 18.PMID: 19151714 [PubMed - indexed for MEDLINE]Related articles

Smallness for gestational age interacts with high mobility group A2 gene genetic variation to modulate height.

Bouatia-Naji N, Marchand M, Cavalcanti-Proença C, Daghmoun S, Durand E, Tichet J, Marre M, Balkau B, Froguel P, Lévy-Marchal C.

Eur J Endocrinol. 2009 Apr;160(4):557-60. Epub 2009 Jan 12.PMID: 19139030 [PubMed - indexed for MEDLINE]Related articles

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.

Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, Sparsø T, Holmkvist J, Marchand M, Delplanque J, Lobbens S, Rocheleau G, Durand E, De Graeve F, Chèvre JC, Borch-Johnsen K, Hartikainen AL, Ruokonen A, Tichet J, Marre M, Weill J, Heude B, Tauber M, Lemaire K, Schuit F, Elliott P, Jørgensen T, Charpentier G, Hadjadj S, Cauchi S, Vaxillaire M, Sladek R, Visvikis-Siest S, Balkau B, Lévy-Marchal C, Pattou F, Meyre D, Blakemore AI, Jarvelin MR, Walley AJ, Hansen T, Dina C, Pedersen O, Froguel P.

Nat Genet. 2009 Jan;41(1):89-94. Epub 2008 Dec 7.PMID: 19060909 [PubMed - indexed for MEDLINE]Related articles

Relationships between common polymorphisms of adenosine triphosphate-binding cassette transporter A1 and high-density lipoprotein cholesterol and coronary heart disease in a population with type 2 diabetes mellitus.

Porchay-Baldérelli I, Péan F, Emery N, Maimaitiming S, Bellili N, Travert F, Mohammedi K, Roussel R, Marre M, Fumeron F; DIABHYCAR Study Group.

Metabolism. 2009 Jan;58(1):74-9.PMID: 19059534 [PubMed - indexed for MEDLINE]Related articles

Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.

Halimi JM, Bonnet F, Lange C, Balkau B, Tichet J, Marre M; DESIR Study Group.

J Hypertens. 2008 Nov;26(11):2198-206.PMID: 18854761 [PubMed - indexed for MEDLINE]Related articles

G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes.

Trégouet DA, Groop PH, McGinn S, Forsblom C, Hadjadj S, Marre M, Parving HH, Tarnow L, Telgmann R, Godefroy T, Nicaud V, Rousseau R, Parkkonen M, Hoverfält A, Gut I, Heath S, Matsuda F, Cox R, Kazeem G, Farrall M, Gauguier D, Brand-Herrmann SM, Cambien F, Lathrop M, Vionnet N; EURAGEDIC Consortium.

Diabetes. 2008 Oct;57(10):2843-50. Epub 2008 Jul 15.PMID: 18633107 [PubMed - indexed for MEDLINE]Related articlesFree article

Common nonsynonymous variants in PCSK1 confer risk of obesity.

Benzinou M, Creemers JW, Choquet H, Lobbens S, Dina C, Durand E, Guerardel A, Boutin P, Jouret B, Heude B, Balkau B, Tichet J, Marre M, Potoczna N, Horber F, Le Stunff C, Czernichow S, Sandbaek A, Lauritzen T, Borch-Johnsen K, Andersen G, Kiess W, Körner A, Kovacs P, Jacobson P, Carlsson LM, Walley AJ, Jørgensen T, Hansen T, Pedersen O, Meyre D, Froguel P.

Nat Genet. 2008 Aug;40(8):943-5. Epub 2008 Jul 6.PMID: 18604207 [PubMed - indexed for MEDLINE]Related articles

The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.

Vaxillaire M, Cavalcanti-Proença C, Dechaume A, Tichet J, Marre M, Balkau B, Froguel P; DESIR Study Group.

Diabetes. 2008 Aug;57(8):2253-7. Epub 2008 Jun 12.PMID: 18556336 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. Epub 2008 Jun 6.PMID: 18539916 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.

Hadjadj S, Fumeron F, Roussel R, Saulnier PJ, Gallois Y, Ankotche A, Travert F, Abi Khalil C, Miot A, Alhenc-Gelas F, Lievre M, Marre M; DIABHYCAR Study Group; DIAB2NEPHROGENE Study Group; SURDIAGENE Study Group.

Diabetes Care. 2008 Sep;31(9):1847-52. Epub 2008 Jun 3.PMID: 18523145 [PubMed - indexed for MEDLINE]Related articlesFree article

The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies.

Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, Marre M, Charpentier G, Froguel P, Meyre D.

BMC Med Genet. 2008 May 22;9:45.PMID: 18498634 [PubMed - indexed for MEDLINE]Related articlesFree article

Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.

Cauchi S, Meyre D, Durand E, Proença C, Marre M, Hadjadj S, Choquet H, De Graeve F, Gaget S, Allegaert F, Delplanque J, Permutt MA, Wasson J, Blech I, Charpentier G, Balkau B, Vergnaud AC, Czernichow S, Patsch W, Chikri M, Glaser B, Sladek R, Froguel P.

PLoS One. 2008 May 7;3(5):e2031.PMID: 18461161 [PubMed - indexed for MEDLINE]Related articlesFree article

A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.

Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, Cavalcanti-Proença C, Marchand M, Hartikainen AL, Sovio U, De Graeve F, Rung J, Vaxillaire M, Tichet J, Marre M, Balkau B, Weill J, Elliott P, Jarvelin MR, Meyre D, Polychronakos C, Dina C, Sladek R, Froguel P.

Science. 2008 May 23;320(5879):1085-8. Epub 2008 May 1.PMID: 18451265 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians.

Duesing K, Fatemifar G, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

Diabetes. 2008 Jul;57(7):1992-6. Epub 2008 Apr 22.PMID: 18430866 [PubMed - indexed for MEDLINE]Related articlesFree article

Does PERISCOPE provide a new perspective on diabetic treatment?

Steg PG, Marre M.

JAMA. 2008 Apr 2;299(13):1603-4. Epub 2008 Mar 31. No abstract available. PMID: 18378632 [PubMed - indexed for MEDLINE]Related articles

Strong association of common variants in the CDKN2A/CDKN2B region with type 2 diabetes in French Europids.

Duesing K, Fatemifar G, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

Diabetologia. 2008 May;51(5):821-6. Epub 2008 Mar 27.PMID: 18368387 [PubMed - indexed for MEDLINE]Related articles

R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population.

Meyre D, Farge M, Lecoeur C, Proenca C, Durand E, Allegaert F, Tichet J, Marre M, Balkau B, Weill J, Delplanque J, Froguel P.

Hum Mol Genet. 2008 Jun 15;17(12):1798-802. Epub 2008 Mar 5.PMID: 18325908 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluating the association of common PBX1 variants with type 2 diabetes.

Duesing K, Charpentier G, Marre M, Tichet J, Hercberg S, Balkau B, Froguel P, Gibson F.

BMC Med Genet. 2008 Feb 29;9:14.PMID: 18312624 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of TCF7L2 polymorphisms on obesity in European populations.

Cauchi S, Choquet H, Gutiérrez-Aguilar R, Capel F, Grau K, Proença C, Dina C, Duval A, Balkau B, Marre M, Potoczna N, Langin D, Horber F, Sørensen TI, Charpentier G, Meyre D, Froguel P.

Obesity (Silver Spring). 2008 Feb;16(2):476-82.PMID: 18239663 [PubMed - indexed for MEDLINE]Related articles

Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study.

Cauchi S, Proença C, Choquet H, Gaget S, De Graeve F, Marre M, Balkau B, Tichet J, Meyre D, Vaxillaire M, Froguel P; D.E.S.I.R. Study Group.

J Mol Med. 2008 Mar;86(3):341-8. Epub 2008 Jan 22.PMID: 18210030 [PubMed - indexed for MEDLINE]Related articles

The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.

Cheurfa N, Dubois-Laforgue D, Ferrarezi DA, Reis AF, Brenner GM, Bouché C, Le Feuvre C, Fumeron F, Timsit J, Marre M, Velho G.

Diabetes. 2008 Apr;57(4):1063-8. Epub 2008 Jan 11.PMID: 18192542 [PubMed - indexed for MEDLINE]Related articlesFree article

Reducing cardiovascular risk in diabetes.

Marre M.

J Hypertens. 2007 Jun;25 Suppl 1:S19-22. Review.PMID: 17579314 [PubMed - indexed for MEDLINE]Related articles

[Prevention of cardiovascular risk in diabetes]

Marre M, Duval-Leclercq M, Travert F.

Rev Prat. 2007 Sep 15;57(13):1423-30. Review. French. PMID: 18018541 [PubMed - indexed for MEDLINE]Related articles

[Diabetes complications. Strict blood glucose controls and beyond]

Marre M.

Rev Prat. 2007 Sep 15;57(13):1409-10. French. No abstract available. PMID: 18018539 [PubMed - indexed for MEDLINE]Related articles

Evaluating the association of common LMNA variants with type 2 diabetes and quantitative metabolic phenotypes in French Europids.

Duesing K, Charpentier G, Marre M, Tichet J, Hercberg S, Froguel P, Gibson F.

Diabetologia. 2008 Jan;51(1):76-81. Epub 2007 Nov 10.PMID: 17994215 [PubMed - indexed for MEDLINE]Related articles

Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study.

Vaxillaire M, Veslot J, Dina C, Proença C, Cauchi S, Charpentier G, Tichet J, Fumeron F, Marre M, Meyre D, Balkau B, Froguel P; DESIR Study Group.

Diabetes. 2008 Jan;57(1):244-54. Epub 2007 Oct 31.PMID: 17977958 [PubMed - indexed for MEDLINE]Related articlesFree article

Minor contribution of SMAD7 and KLF10 variants to genetic susceptibility of type 2 diabetes.

Gutierrez-Aguilar R, Benmezroua Y, Balkau B, Marre M, Helbecque N, Charpentier G, Polychronakos C, Sladek R, Froguel P, Neve B.

Diabetes Metab. 2007 Nov;33(5):372-8. Epub 2007 Oct 10.PMID: 17931948 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of perindopril in hypertensive patients with or without type 2 diabetes mellitus, and with altered insulin sensitivity.

Marre M, Leye A.

Diab Vasc Dis Res. 2007 Sep;4(3):163-73. Review.PMID: 17907106 [PubMed - indexed for MEDLINE]Related articles

Reducing cardiovascular risk in diabetes.

Marre M.

J Hypertens Suppl. 2007 Jun;25(1):S19-22. Review.PMID: 17874529 [PubMed - indexed for MEDLINE]Related articles

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

Lancet. 2007 Sep 8;370(9590):829-40.PMID: 17765963 [PubMed - indexed for MEDLINE]Related articles

ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study.

Meyre D, Bouatia-Naji N, Vatin V, Veslot J, Samson C, Tichet J, Marre M, Balkau B, Froguel P.

Diabetologia. 2007 Oct;50(10):2090-6. Epub 2007 Aug 18.PMID: 17704904 [PubMed - indexed for MEDLINE]Related articles